Relationship between white matter changes and cognition in healthy elders

Miho Ota1, Kiyotaka Nemoto, Noriko Sato

  • 1Department of Radiology, Musashi Hospital, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, Tokyo, Japan. ota@ncnp.go.jp

Abstract

Insights

White matter hyperintensities (WMHs) in older adults are linked to cognitive changes. Even in healthy individuals, severe WMHs can impact attention and time orientation based on their location.

Area of Science:

  • Neuroimaging
  • Cognitive Neuroscience
  • Gerontology

Background:

  • Cerebral white matter hyperintensities (WMHs) are frequently observed on T2-weighted MRI in healthy elderly individuals.
  • The clinical significance of these incidental findings regarding cognitive function is not fully understood.

Purpose of the Study:

  • To investigate the association between the extent of white matter changes and cognitive performance in cognitively healthy older adults.
  • To determine if the localization of white matter hyperintensities influences cognitive outcomes.

Main Methods:

  • A cohort of 172 cognitively healthy subjects underwent magnetic resonance imaging (MRI) and comprehensive neuropsychological testing.
  • White matter hyperintensities (WMHs) were systematically graded using a four-point scale on T2-weighted MRI sequences.
  • Cognitive function was assessed across various domains, including attention and temporal orientation.

Main Results:

  • Subjects with the most severe white matter hyperintensities (WMHs) demonstrated significantly poorer performance in attention compared to those without WMHs.
  • Severe WMHs in the parieto-occipital regions were associated with impaired disorientation to time.
  • The frontal and basal ganglia regions showed distinct patterns of cognitive impact related to WMH severity.

Conclusions:

  • The presence and severity of white matter hyperintensities (WMHs) can subtly affect cognitive function in cognitively healthy elderly individuals.
  • The specific cognitive domains impacted by WMHs are dependent on their anatomical location within the brain.
  • These findings highlight the importance of considering WMHs in the assessment of cognitive aging.

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Language and Cognition01:27

Language and Cognition

Language serves as a bridge between ideas and communication, influencing how individuals perceive and interact with the world. Psychologists have long debated whether language shapes thought or vice versa. This discussion gained grip with Edward Sapir and Benjamin Lee Whorf in the 1940s, who proposed that language determines thought, a concept known as linguistic determinism. They suggested that the vocabulary and structure of a language influence how its speakers think and perceive reality.
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...